Page last updated: 2024-08-24

dehydroabietylamine and Breast Cancer

dehydroabietylamine has been researched along with Breast Cancer in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Ahn, KS; Jung, YY; Sethi, G; Um, JY	1

Other Studies

1 other study(ies) available for dehydroabietylamine and Breast Cancer

Article	Year
Potential Application of Leelamine as a Novel Regulator of Chemokine-Induced Epithelial-to-Mesenchymal Transition in Breast Cancer Cells. International journal of molecular sciences, 2022, Aug-30, Volume: 23, Issue:17 Topics: Abietanes; Breast Neoplasms; Cell Line, Tumor; Cell Movement; Cell Proliferation; Chemokine CXCL12; Epithelial-Mesenchymal Transition; Female; Humans; Janus Kinases; Reactive Oxygen Species; Receptors, CXCR; Receptors, CXCR4; Signal Transduction; STAT Transcription Factors	2022

Article

Year

Potential Application of Leelamine as a Novel Regulator of Chemokine-Induced Epithelial-to-Mesenchymal Transition in Breast Cancer Cells.

International journal of molecular sciences, 2022, Aug-30, Volume: 23, Issue:17

Topics: Abietanes; Breast Neoplasms; Cell Line, Tumor; Cell Movement; Cell Proliferation; Chemokine CXCL12; Epithelial-Mesenchymal Transition; Female; Humans; Janus Kinases; Reactive Oxygen Species; Receptors, CXCR; Receptors, CXCR4; Signal Transduction; STAT Transcription Factors

2022